Similar articles

• Hemophiliacs and acquired immune deficiency syndrome.

  Lin TA, Zhao JQ, Rabin B. Lin TA, et al. Chin Med J (Engl). 1985 Jun;98(6):444-6. Chin Med J (Engl). 1985. PMID: 2996841 No abstract available.
• The significance of non-A, non-B hepatitis, cytomegalovirus and the acquired immune deficiency syndrome in transfusion practice.

  Bayer WL, Tegtmeier GE, Barbara JA. Bayer WL, et al. Clin Haematol. 1984 Feb;13(1):253-69. Clin Haematol. 1984. PMID: 6327132 Review. No abstract available.
• [Virus infections caused by transfusion of blood and blood products. 2: Parvovirus, cytomegalovirus, Epstein-Barr virus, human immunodeficiency virus].

  Roggendorf M. Roggendorf M. Fortschr Med. 1987 Apr 10;105(10):184-6. Fortschr Med. 1987. PMID: 3034751 German. No abstract available.
• Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group.

  Lang DJ, Kovacs AA, Zaia JA, Doelkin G, Niland JC, Aledort L, Azen SP, Fletcher MA, Gauderman J, Gjerset GJ, et al. Lang DJ, et al. J Acquir Immune Defic Syndr (1988). 1989;2(6):540-9. J Acquir Immune Defic Syndr (1988). 1989. PMID: 2555471
• Risk assessment in haematopoietic stem cell transplantation: viral status.

  Ljungman P. Ljungman P. Best Pract Res Clin Haematol. 2007 Jun;20(2):209-17. doi: 10.1016/j.beha.2006.09.003. Best Pract Res Clin Haematol. 2007. PMID: 17448957 Review.